<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="53652">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT01919931</url>
  </required_header>
  <id_info>
    <org_study_id>S55012</org_study_id>
    <nct_id>NCT01919931</nct_id>
  </id_info>
  <brief_title>Immunological Interaction Between the Host and Candida Albicans Biofilm</brief_title>
  <official_title>Immunological and Molecular Interaction Between the Host and Candida Albicans Biofilm</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Universitaire Ziekenhuizen Leuven</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Universitaire Ziekenhuizen Leuven</source>
  <oversight_info>
    <authority>Belgium: Institutional Review Board</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Candida albicans is one of the most common nosocomial infection and the onset relies on the
      host immune status. The purpose of this study is to determine the immunological profile of
      patients infected with Candida albicans, that could ideally lead to a strategy to identify
      patients who could benefit from prophylaxis.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>March 2013</start_date>
  <completion_date type="Anticipated">December 2016</completion_date>
  <primary_completion_date type="Anticipated">December 2013</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Observational</study_type>
  <study_design>Observational Model: Case Control, Time Perspective: Cross-Sectional</study_design>
  <primary_outcome>
    <measure>Immunological phenotyping of patients</measure>
    <time_frame>2 months</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <secondary_outcome>
    <measure>Mannose Binding Lectin levels</measure>
    <time_frame>1 month</time_frame>
    <safety_issue>No</safety_issue>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">140</enrollment>
  <condition>Candidiasis</condition>
  <arm_group>
    <arm_group_label>Candida Infection</arm_group_label>
    <description>Patients infected with Candida albicans</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No infection</arm_group_label>
    <description>Patients with no Candida albicans infection</description>
  </arm_group>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Samples to be retained: whole blood, Plasma and White cells.
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with Candida albicans infection. Patients with no Candida albicans infection.
        Healthy volunteers
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients infected with Candida albicans

          -  Patients not infected with Candida albicans

        Exclusion Criteria:

          -  Underage patients

          -  Non consenting patients

          -  Unconscious patients
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Adrian Liston, Group Leader</last_name>
    <role>Study Director</role>
    <affiliation>Flemish Institute of Biotechnology</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Adrian Liston, PI</last_name>
    <phone>+32 16 33 09 34</phone>
    <email>adrian.liston@vib-kuleuven.be</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Josselyn Garcia, PhD student</last_name>
    <phone>+32 16 33 09 34</phone>
    <email>josselyn.garciaperez@student.kuleuven.be</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Flemish Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Adrian Liston, Group Leader</last_name>
      <phone>+32 16 33 09 34</phone>
      <email>adrian.liston@vib-kuleuven.be</email>
    </contact>
    <contact_backup>
      <last_name>Josselyn Garcia, PhD student</last_name>
      <phone>+32 16 33 09 34</phone>
      <email>josselyn.garciaperez@student.kuleuven.be</email>
    </contact_backup>
    <investigator>
      <last_name>Adrian Liston, Group Leader</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Universitair Ziekenhuis Leuven</name>
      <address>
        <city>Leuven</city>
        <state>Flemish Brabant</state>
        <zip>3000</zip>
        <country>Belgium</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Katrien Lagrou, MD</last_name>
      <phone>003216347098</phone>
      <phone_ext>47098</phone_ext>
      <email>katrien.lagrou@uzleuven.be</email>
    </contact>
    <investigator>
      <last_name>Adrian Liston, PhD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <verification_date>January 2013</verification_date>
  <lastchanged_date>August 6, 2013</lastchanged_date>
  <firstreceived_date>June 19, 2013</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Candida albicans</keyword>
  <keyword>Candidiasis</keyword>
  <keyword>Biofilm</keyword>
  <keyword>Flow cytometry</keyword>
  <keyword>Mannose Binding Lectin</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Candidiasis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
